BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36984548)

  • 1. Predictive Value of Gene Databases in Discovering New Biomarkers and New Therapeutic Targets in Lung Cancer.
    Liu M; Yu X; Qu C; Xu S
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984548
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of key genes and biological pathways in Chinese lung cancer population using bioinformatics analysis.
    Liu P; Li H; Liao C; Tang Y; Li M; Wang Z; Wu Q; Zhou Y
    PeerJ; 2022; 10():e12731. PubMed ID: 35178291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values.
    Wang T; Chen X; Jing F; Li Z; Tan H; Luo Y; Shi H
    Pathol Res Pract; 2021 Dec; 228():153654. PubMed ID: 34749208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
    Dong S; Men W; Yang S; Xu S
    Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AURKA Identified as Potential Lung Cancer Marker through Comprehensive Bioinformatic Analysis and Experimental Verification.
    Shi S; Qiu Y; Jin Z; Zhou J; Yu W; Zhang H
    Crit Rev Eukaryot Gene Expr; 2023; 33(5):39-59. PubMed ID: 37199313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Hub Biomarkers and Immune-Related Pathways Participating in the Progression of Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Xia MD; Yu RR; Chen DM
    Front Immunol; 2021; 12():809325. PubMed ID: 35069594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Transcriptional Pattern Related to Immune Cell Infiltration With Gene Co-Expression Network in Papillary Thyroid Cancer.
    Li M; Zhang J; Zhang Z; Qian Y; Qu W; Jiang Z; Zhao B
    Front Endocrinol (Lausanne); 2022; 13():721569. PubMed ID: 35185791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.
    Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma.
    Zhang Y; Tang Y; Guo C; Li G
    Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
    Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
    Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of hub biomarkers and immune cell infiltration characteristics of polymyositis by bioinformatics analysis.
    Jia Q; Hao RJ; Lu XJ; Sun SQ; Shao JJ; Su X; Huang QF
    Front Immunol; 2022; 13():1002500. PubMed ID: 36225941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression modules construction by WGCNA and identify potential hub genes and regulation pathways of postpartum depression.
    Deng Z; Cai W; Liu J; Deng A; Yang Y; Tu J; Yuan C; Xiao H; Gao W
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1019-1030. PubMed ID: 34856750
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis.
    Chen X; Wang J; Peng X; Liu K; Zhang C; Zeng X; Lai Y
    Medicine (Baltimore); 2020 Apr; 99(14):e19628. PubMed ID: 32243390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of hub driving genes and regulators of lung adenocarcinoma based on the gene Co-expression network.
    Xu Z; Wu Z; Xu J; Zhang J; Yu B
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32196072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression network analysis identifies potential candidate hub genes in severe influenza patients needing invasive mechanical ventilation.
    Chen L; Hua J; He X
    BMC Genomics; 2022 Oct; 23(1):703. PubMed ID: 36243706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma.
    Gao J; Lu F; Yan J; Wang R; Xia Y; Wang L; Li L; Chang L; Li W
    Front Immunol; 2022; 13():992626. PubMed ID: 36311724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.